Latest Market Research Report 2025

  Active Pharmaceutical Ingredients (API) Market Growth & Trends The global  active pharmaceutical ingredients (API) market  is expected to reach a valuation of USD 359.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.85% from 2025 to 2030, according to a recent report by Grand View Research, Inc. This growth is primarily driven by the rapid expansion of the biopharmaceutical sector, continuous technological advancements in API manufacturing, and the rising aging population, which is leading to a greater demand for pharmaceuticals globally. One of the key growth drivers is the increasing investment in captive API production, where pharmaceutical companies focus on developing in-house manufacturing capabilities. By doing so, companies can reduce costs, ensure quality control, and mitigate the risk of contamination associated with outsourcing. Advances in artificial intelligence (AI) and protein synthesis technologies are further streamlining API...

  Active Pharmaceutical Ingredients Industry Overview The global  active pharmaceutical ingredients market  size is expected to reach USD 353.0 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical Ingredients (API) manufacturing, and an increase in the geriatric population.   Active Pharmaceutical Ingredients Market Segmentation Grand View Research has segmented the global active pharmaceutical Ingredients market based on the type of synthesis, type of manufacturer, type, application, and region:   Based on the Type of Synthesis Insights, the market is segmented into Biotech and Synthetic. The synthetic API segment accounted for the largest revenue share of 72.6% in 2021. This is attributed to the higher availability of raw materials and easier pr...